Crystal Structure Of Anti-Cancer Drug Shows How Drug Disables Harmful Copper In Cells
Links shared publicly online about this topic.
- 1,570total visits
Crystal Structure Of Anti-Cancer Drug Shows How Drug Disables Harmful Copper In Cells
The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic
View full resource at medicalnewstoday.com
Tags: Wilson Disease, Disease and Condition, Mineral, Copper, Drug
Most Recently Shared on November 28, 2009 at 11:34 pm By:
Crystal Structure Of Anti-Cancer Drug Shows How Drug Disables Harmful Copper In Cells: The copper sequestering drug... http://bit.ly/6Iz56N
Also Shared By:
Advertisement
MNT Cancer News
@mnt_cancer
Crystal Structure Of Anti-Cancer Drug Shows How Drug Disables Harmful Copper In Cells: The copper sequestering drug... http://bit.ly/6Iz56N
1 year ago...